NCT04912323View on ClinicalTrials.gov

Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 17, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2031

Conditions
Peripheral Arterial DiseaseAtherosclerotic LesionLower Extremity IschemiaLower Extremity Claudication
Interventions
DEVICE

Percutaneous Implantation of the MAGNITUDE® Bioresorbable Arterial Scaffold

Placement of one or more MAGNITUDE® bioresorbable scaffolds using a percutaneous technique at one or more arterial stenoses.

Trial Locations (7)

Unknown

RECRUITING

Medical University Graz, Graz

RECRUITING

CRCHUM Université Montreal, Montreal

ACTIVE_NOT_RECRUITING

Hopital Saint-Francois d'Assise, Québec

RECRUITING

Toronto General Hospital, Toronto

RECRUITING

San Donato Hospital, Arezzo

RECRUITING

Maria Cecilia Hospital, Cotignola

RECRUITING

IRCCS Multimedica, Milan

All Listed Sponsors
collaborator

Massachusetts General Physicians Organization / Vascore

UNKNOWN

collaborator

Cardiovascular Research Foundation, New York

OTHER

lead

R3 Vascular Inc.

INDUSTRY